Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02576002 · ClinicalTrials.gov registry record
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
A clinical trial of Hypertension, Pulmonary, sponsored by Bayer.
- Completed
- Registry status
- 2,691
- Enrollment target
- 1
- Study location
NCT02576002: Completed study of Hypertension, Pulmonary, sponsored by Bayer.
NCT02576002 is a study of Hypertension, Pulmonary that has completed, run by Bayer. The registered enrollment target is 2,691 participants, above the 476-participant average among 10 other Hypertension, Pulmonary trials with a reported enrollment target (465% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02576002, a study of Hypertension, Pulmonary, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 2,691 participants
- Enrollment target
- 1
- Study location
Study Summary
To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013
Conditions Studied
Interventions
- DRUG Assigned pulmonary hypertension medication
Study Locations (1)
Massachusetts
- - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,691 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-01 |
What the finished NCT02576002 record still lists
NCT02576002 is an observational study that tracks outcomes without assigning an intervention. Its 2,691 participants enrollment target places it among the larger protocols in the corpus, above the 476-participant average among 10 other Hypertension, Pulmonary trials with a reported enrollment target (465% higher).
The record links to 1 condition, with Hypertension, Pulmonary appearing as the primary indexed condition, and to 1 intervention - of which Assigned pulmonary hypertension medication is the first listed.
NCT02576002 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02576002 about?
NCT02576002 is a clinical study titled "Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)". To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013
What is the current status of trial NCT02576002?
This trial is currently completed. The enrollment target is 2,691 participants. The study started on 2015-10. Estimated completion is 2016-01.
What conditions does trial NCT02576002 study?
This clinical trial studies the following conditions: Hypertension, Pulmonary.
What interventions are being tested in trial NCT02576002?
The interventions under investigation include: Assigned pulmonary hypertension medication (DRUG).
Who is sponsoring clinical trial NCT02576002?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02576002 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension, Pulmonary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02576002's enrollment target sits among peer trials
2,691 2nd of 10 the highest of 10 other Hypertension, Pulmonary trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension, Pulmonary trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
RECRUITING
-
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
RECRUITING · Phase 2
-
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
ACTIVE NOT RECRUITING · Phase 2
-
Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD
ACTIVE NOT RECRUITING · NA
-
Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05111925 · 2,690 participants
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia